Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| February 13, 2024 | 14.81 |
| February 12, 2024 | 14.81 |
| February 09, 2024 | 14.81 |
| February 08, 2024 | 14.81 |
| February 07, 2024 | 14.01 |
| February 06, 2024 | 13.99 |
| February 05, 2024 | 13.89 |
| February 02, 2024 | 13.87 |
| February 01, 2024 | 13.92 |
| January 31, 2024 | 13.90 |
| January 30, 2024 | 13.93 |
| January 29, 2024 | 13.95 |
| January 26, 2024 | 14.02 |
| January 25, 2024 | 13.99 |
| January 24, 2024 | 13.99 |
| January 23, 2024 | 13.96 |
| January 22, 2024 | 14.01 |
| January 19, 2024 | 14.00 |
| January 18, 2024 | 14.00 |
| January 17, 2024 | 14.03 |
| January 16, 2024 | 14.05 |
| January 12, 2024 | 14.11 |
| January 11, 2024 | 14.08 |
| January 10, 2024 | 14.11 |
| January 09, 2024 | 14.17 |
| Date | Value |
|---|---|
| January 08, 2024 | 14.15 |
| January 05, 2024 | 14.06 |
| January 04, 2024 | 14.00 |
| January 03, 2024 | 13.99 |
| January 02, 2024 | 14.06 |
| December 29, 2023 | 14.06 |
| December 28, 2023 | 14.09 |
| December 27, 2023 | 14.16 |
| December 26, 2023 | 14.15 |
| December 22, 2023 | 14.08 |
| December 21, 2023 | 14.08 |
| December 20, 2023 | 13.97 |
| December 19, 2023 | 14.16 |
| December 18, 2023 | 13.97 |
| December 15, 2023 | 13.96 |
| December 14, 2023 | 13.97 |
| December 13, 2023 | 14.20 |
| December 12, 2023 | 14.09 |
| December 11, 2023 | 14.06 |
| December 08, 2023 | 13.85 |
| December 07, 2023 | 13.92 |
| December 06, 2023 | 13.91 |
| December 05, 2023 | 13.85 |
| December 04, 2023 | 13.85 |
| December 01, 2023 | 13.90 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.267
Minimum
Jun 13 2022
38.50
Maximum
Jun 23 2023
11.02
Average
7.955
Median
Price to Book Value Benchmarks
| AbbVie Inc | 27.22 |
| Pfizer Inc | 1.611 |
| Johnson & Johnson | 5.121 |
| Merck & Co Inc | 8.843 |
| Cerevel Therapeutics Holdings Inc | 11.45 |
Price to Book Value Related Metrics
| Price | 31.23 |